Chang, H-R <br/><br/>
Sirolimus addition is beneficial for renal allograft dysfunction due to simultaneous acute rejection episode and calcineurin inhibitor nephrotoxicity.  [electronic resource] 

 -  Transplantation proceedings  Nov 2004 
 - 2668-70 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2004.09.060  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Calcineurin Inhibitors<br/>Cyclosporine--therapeutic use<br/>Diabetic Nephropathies--surgery<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Failure, Chronic--surgery<br/>Kidney Transplantation--immunology<br/>Male<br/>Reoperation<br/>Sirolimus--therapeutic use<br/>Tacrolimus--therapeutic use<br/>Treatment Outcome